US 7662820
Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon
granted A61PA61P31/00A61P35/00
Quick answer
US patent 7662820 (Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon) held by SanRx Pharmaceuticals, Inc. expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SanRx Pharmaceuticals, Inc.
- Grant date
- Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P31/00, A61P35/00, A61P37/00